29th European Society of Medical Oncologists Congress

- , Austria Center, Vídeň, Rakousko

Aktivní účast z České republiky na ESMO 2004:

Oral Presentation

1. Petra Kleiblova, Zdenek Kleibl, Jan Novotny, Lubos Petruzelka
Analysis of dihydropyrimidine dehydrogenase [DPD] coding sequence variants in patients with serious fluoropyrimidines toxicity
Oral Presentation. Abstract: 380O
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004

Poster Discussions:

2. Kell Oesterlind, Jose Sanchez, Petr Zatloukal, Michael Perry, John Hamm, Chandra Belani, Edward Kim, Johan Vansteenkiste, Enriqueta Felip, Myriam Berton
A phase I/II dose-escalation trial of patupilone (EPO906) administered every 3 weeks in patients with non-small cell lung cancer (NSCLC)
Poster Discussion. Abstract: 631PD
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004

Poster Presentations:

3. Lubos Holubec, Jindrich Finek, Jiri Salvet, Ondrej Topolcan, Sarka Svobodova, Martin Matoulek, Stepan Svacina, Vladimir Visokai, Ludmila Lipska
Alteration of cardiac markers (BNP and troponin I) in the course of chemotherapy of patients with colorectal carcinoma
Poster Presentation. Abstract: 356P
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
4. Tomas Buchler, Eva Dolezelova, Pavel Fabian, Ludek Pour, Mojmir Moulis, Leos Kren, Zdenek Adam, Marta Krejci, Roman Hajek, Jiri Vorlicek
The expression of CD56 on malignant plasmocytes and bone disease in patients with multiple myeloma
Poster Presentation, Abstract: 618P,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
5. L. Petruzelka, M. Zimovjanova, B. Konopasek, P. Mares, Z. Dlouha
Fulvestrant in postmenopausal women with metastatic breast cancer progressing on prior endocrine therapy - updated results from an expanded access programme
Poster Presentation, Abstract: 136P,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
6. Michal Zikan, Jan Novotny, Petr Pohlreich, Zdenek Kleibl, Marketa Janatova
High frequency of population-specific mutations of BRCA genes among breast cancer patients in the Czech Republic
Poster Presentation, Abstract: 821P,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
7. Bohuslav Melichar, Esther Casado, Josep Tabernero, Sharareh Hosseinzadeh, John Hamm, Scott Wadler, John Bridgewater, Jaymes Holland, Ivo Sklenar, Anandhi Johri
Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer
Poster Presentation, Abstract: 317P, Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
8. Ugo De Giorgi, Taner Demirer, Hannes Wandt, Christian Taverna, Wolfgang Siegert, Martin Bornhauser, Tomas Kozak, Giorgio Papiani, Michela Ballardini, Giovanni Rosti
Second-line high-dose chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the experience of the European Group for Blood and Marrow Transplantation (EBMT)
Poster Presentation, Abstract: 452P,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
9. Vladimir Boudny, Lenka Adamkova, Ludmila Lauerova, Ivo Kocak, Jan Kovarik
STAT 1 phosphorylation induced by interferons in human malignant melanoma
Poster Presentation, Abstract: 84P,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
10. Anna Dmoszynska, Janusz Kloczko, Malgorzata Rokicka, Andrzej Hellmann, Ivan Spicka
Continuous Erythropoiesis Receptor Activator (CERA) produces dose-related erythropoietic activity in patients with multiple myeloma
Poster Presentation, Abstract: 593P
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
11. Dagmar Brančíková, Dagmar Krákorová-Adámková, Helena Čoupková, Vladimir Spurný, Kristina Divišová
The treatment metastatic colorectal cancer (MCC) by regimen TOMOX - our experiences
Poster Presentation, Abstract: 351P
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
12. Maya Gottfried, Rodryg Ramlau, Maciej Krzakowski, Leona Novakova, Aleksandra Szczesna, Ramon Barcelo, Reury-Perng Perng, Dominique Grunenwald
The Vinorelbine (NAVELBINE/NVB)-based triplet with Ifosfamide (IFO) and Cisplatin (NIP) allows resection in marginally unresectable Non-Small Cell Lung Cancer (NSCLC) patients (pts) without delay in surgery
Poster Presentation, Abstract: 653P
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004

Publication

13. Dagmar Adámková-Krákorová, Vladimir Spurny, Dagmar Brancikova, Renata Cervena
Neoadjuvant chemoradiotherapy for rectal cancer: our experience
Publication Only, Abstract: 370,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004
14. Milada Zemanova, Martin Haluzík, Frantisek Novák, Alexandr Pazdro, Eva Tvrzicka, Gabriela Pazdrova, Lubos Petruzelka
Nutritional status, serum leptin, fatty acids and TNF-á level in oesophageal cancer patients treated with preoperative chemoradiotherapy: A pilot study
Publication Only, Abstract: 937,
Citation: Annals of Oncology, Volume 15, Supplement 3, 2004

 

Pozvání na událost

29th European Society of Medical Oncologists Congress se konal v roce 2004.

Konferenční abstrakta

Příští kongres ESMO

Organizační informace a program sjezdu ESMO najdete v v kalendáři akcí

Pozvánka na akci

Registrace před kongresem je již uzavřena! Můžete se však zaregistrovat přímo na místě od pátku 29.10. 2004 v Austria Center Vienna
Skupinová registrace: 23.8.2004
Pozdníregistrace: 20.9.2004
Rezervace ubytování: 27.9.2004 Odborný program
Konferenční abstrakta budou uveřejněna v oficiálním ESMO časopise Annals of Oncology. Objednejte si zaslání obsahu e-mailem.

Kontakt: alessia@esmo.org

Web: http://www.esmo.org/congress2004/

  • Přidat do kalendáře: 2004-10-29 00:00:00 2004-11-02 23:59:59 Europe/Prague 29th European Society of Medical Oncologists Congress 29th European Society of Medical Oncologists Congress se konal v roce 2004. Austria Center, Vídeň, Rakousko